Skip to main content
Log in

Effect of discontinuing of laronidase in a patient with mucopolysaccharidosis type I

  • Short Report
  • Published:
Journal of Inherited Metabolic Disease

Summary

We present a patient on enzyme replacement therapy who showed rapid deterioration when laronidase was discontinued owing to pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Elstein Y, Eisenberg V, Granovsky-Grisaru S, et al (2004) Pregnancies in Gaucher disease: a 5-year study. Am J Obstet Gynecol 190: 435–441.

    Article  PubMed  Google Scholar 

  • Kakkis ED, Muenzer J, Tiller GE, et al (2001) Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med 344: 182–188.

    Article  CAS  PubMed  Google Scholar 

  • Wraith JE, Clarke LA, Beck M, et al (2004) Enzyme replacement therapy for mucopolysaccharidosis I: a randomised, double-Blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (laronidase). J Pediatr 144: 581–588.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. E. Wraith.

Additional information

Communicating editor: Michael Gibson

Competing interests: None declared

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anbu, A.T., Mercer, J. & Wraith, J.E. Effect of discontinuing of laronidase in a patient with mucopolysaccharidosis type I. J Inherit Metab Dis 29, 230–231 (2006). https://doi.org/10.1007/s10545-006-0237-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-006-0237-8

Keywords

Navigation